DK0814790T3 - Indgivelse af ketamin med henblik på afgiftning - Google Patents

Indgivelse af ketamin med henblik på afgiftning

Info

Publication number
DK0814790T3
DK0814790T3 DK96906452T DK96906452T DK0814790T3 DK 0814790 T3 DK0814790 T3 DK 0814790T3 DK 96906452 T DK96906452 T DK 96906452T DK 96906452 T DK96906452 T DK 96906452T DK 0814790 T3 DK0814790 T3 DK 0814790T3
Authority
DK
Denmark
Prior art keywords
ketamine
administration
present
substance addiction
treatment
Prior art date
Application number
DK96906452T
Other languages
Danish (da)
English (en)
Inventor
Stuart L Weg
Original Assignee
Stuart L Weg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1995/002418 external-priority patent/WO1995022965A2/fr
Priority claimed from US08/477,365 external-priority patent/US5679714A/en
Application filed by Stuart L Weg filed Critical Stuart L Weg
Application granted granted Critical
Publication of DK0814790T3 publication Critical patent/DK0814790T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Addiction (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Toxicology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK96906452T 1995-02-24 1996-02-14 Indgivelse af ketamin med henblik på afgiftning DK0814790T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/US1995/002418 WO1995022965A2 (fr) 1994-02-25 1995-02-24 Administration nasale et oculaire de ketamine pour le traitement de la douleur et les desintoxications
US08/477,365 US5679714A (en) 1995-06-07 1995-06-07 Administration of ketamine for detoxification and treatment of tobacco addiction
PCT/US1996/002047 WO1996025925A1 (fr) 1995-02-24 1996-02-14 Administration nasale et oculaire de ketamine pour soulager la douleur ou assurer une desintoxication

Publications (1)

Publication Number Publication Date
DK0814790T3 true DK0814790T3 (da) 2003-11-10

Family

ID=26789531

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96906452T DK0814790T3 (da) 1995-02-24 1996-02-14 Indgivelse af ketamin med henblik på afgiftning

Country Status (9)

Country Link
EP (1) EP0814790B1 (fr)
JP (1) JP4173538B2 (fr)
AT (1) ATE245024T1 (fr)
AU (1) AU733284B2 (fr)
CA (1) CA2213567C (fr)
DE (1) DE69629108T2 (fr)
DK (1) DK0814790T3 (fr)
ES (1) ES2205018T3 (fr)
WO (1) WO1996025925A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111643449A (zh) 2013-03-15 2020-09-11 詹森药业有限公司 S-盐酸氯胺酮的药物组合物
EP3725307A1 (fr) 2014-09-15 2020-10-21 Janssen Pharmaceutica NV Régimes posologiques spécifiques au génotype val66met (snp rs6265) et procédés pour le traitement de la dépression
US10555952B2 (en) 2015-06-19 2020-02-11 Melt Pharmaceuticals, Inc. Pharmaceutical compositions and methods for anesthesiological applications
US10166240B2 (en) 2015-06-19 2019-01-01 Imprimis Pharmaceuticals, Inc. Pharmaceutical compositions and methods for anesthesiological applications
US10179136B2 (en) 2015-06-19 2019-01-15 Imprimis Pharmaceuticals, Inc. Pharmaceutical compositions and methods for anesthesiological applications
US10391102B2 (en) 2015-06-19 2019-08-27 Melt Pharmaceuticals, Inc. Pharmaceutical compositions and methods for anesthesiological applications
US9918993B2 (en) * 2015-06-19 2018-03-20 Imprimis Pharmaceuticals, Inc. Pharmaceutical compositions for anesthesiological applications
US20200009081A1 (en) 2017-09-13 2020-01-09 Janssen Pharmaceutica N.V. Delivery Of Esketamine For The Treatment Of Depression
SG11202005896WA (en) 2017-12-22 2020-07-29 Janssen Pharmaceuticals Inc Esketamine for the treatment of depression
ES2907692T3 (es) * 2017-12-29 2022-04-26 Celon Pharma Sa Composición de ketamina de polvo seco para su administración por vía pulmonar en la depresión resistente al tratamiento
MX2021010683A (es) 2019-03-05 2021-12-10 Janssen Pharmaceuticals Inc Esketamina para el tratamiento de la depresión.
CN116942648A (zh) * 2022-04-26 2023-10-27 宜昌人福药业有限责任公司 艾司氯胺酮液体制剂及其用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5288498A (en) * 1985-05-01 1994-02-22 University Of Utah Research Foundation Compositions of oral nondissolvable matrixes for transmucosal administration of medicaments
US5543434A (en) * 1994-02-25 1996-08-06 Weg; Stuart L. Nasal administration of ketamine to manage pain

Also Published As

Publication number Publication date
WO1996025925A1 (fr) 1996-08-29
DE69629108T2 (de) 2004-04-22
AU733284B2 (en) 2001-05-10
CA2213567C (fr) 2010-01-26
EP0814790A1 (fr) 1998-01-07
DE69629108D1 (de) 2003-08-21
ATE245024T1 (de) 2003-08-15
AU4982796A (en) 1996-09-11
ES2205018T3 (es) 2004-05-01
CA2213567A1 (fr) 1996-08-29
JP4173538B2 (ja) 2008-10-29
JPH11500729A (ja) 1999-01-19
EP0814790B1 (fr) 2003-07-16

Similar Documents

Publication Publication Date Title
MX9603633A (es) Administracion nasal y ocular de ketamina para manejar el dolor y para la detoxificacion.
DK0814790T3 (da) Indgivelse af ketamin med henblik på afgiftning
ATE276676T1 (de) Zusammensetzung zur reduzierung oder entwöhnung von nikotinabhängigkeit
NO20060913L (no) Behandling av avhengighetsabstinens
CA1152003A (fr) Produit et methode pour combattre le tabagisme chez les particuliers
MY127739A (en) Use of pramipexole for the treatment of addictive disorders
DK0863760T3 (da) Anvendelse af forbindelser med antimineralcorticoid virkning over for narkotikafvænning
WO2001080837A3 (fr) Formes galeniques transdermiques ou transmucosiques comprenant une combinaison de principes actifs contenant de la nicotine, pour desintoxication de fumeurs
EA004184B1 (ru) Способ уменьшения или прекращения курения
UA27884C2 (uk) Засіб для лікування розладів, викликаних зловживанням ліками та спосіб лікування або профілактики зазначеним засобом абстинентного синдрому
ATE301462T1 (de) Verwendung von reboxetine zur behandlung neuropsychiatrischer beschwerden
US6224897B1 (en) Methods to abate the use of tobacco by humans
MX9706456A (es) Administracion nasal y ocular de la cetamina para manejar el dolor y para la destoxificacion.
Richmond et al. Controlled Trial of the 24-Hour Transdermal Nicotine Patch in Conjunction With Cognitive-Behavioural Therapy: 6-Months’ Results
JP2004505053A (ja) 喫煙の減少または解消方法
SU1537259A1 (ru) Средство, подавл ющее влечение к никотину и табачному дыму
Hendrie Alternative strategies and new treatments for smoking
PROTOCOL Western Regional Emergency Medical Advisory Committee
Radzius et al. Cigarette Smoking not Affected by Cocaine Self-Administration
UA42352A (uk) Спосіб лікування хронічного гастродуоденіту із супутніми захворюваннями внутрішніх органів